Targeted Deep DNA Methylation Analysis of Circulating Cell-free DNA in Plasma Using Massively Parallel Semiconductor Sequencing

References

• Suzuki N , KamatakiA , YamakiJ , HommaY . Characterization of circulating DNA in healthy human plasma . Clin. Chim. Acta387 ( 1–2 ), 55 – 58 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Perkins G , YapTA , PopeLet al. Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers . PLoS ONE7 ( 11 ), e47020 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Dawson SJ , TsuiDW , MurtazaMet al. Analysis of circulating tumor DNA to monitor metastatic breast cancer . N. Engl. J. Med.368 ( 13 ), 1199 – 1209 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Lee YJ , YoonKA , HanJYet al. Circulating cell-free DNA in plasma of never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy . Clin. Cancer Res.17 ( 15 ), 5179 – 5187 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Chan KC , JiangP , ZhengYWet al. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing . Clin. Chem.59 ( 1 ), 211 – 224 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Nakamura T , Sueoka-AraganeN , IwanagaKet al. A noninvasive system for monitoring resistance to epidermal growth factor receptor tyrosine kinase inhibitors with plasma DNA . J. Thorac. Oncol.6 ( 10 ), 1639 – 1648 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Yam I , LamDC , ChanKet al. EGFR array: uses in the detection of plasma EGFR mutations in non-small cell lung cancer patients . J. Thorac. Oncol.7 ( 7 ), 1131 – 1140 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Taniguchi K , UchidaJ , NishinoKet al. Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas . Clin. Cancer Res.17 ( 24 ), 7808 – 7815 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Ramirez JL , SarriesC , De CastroPLet al. Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients . Cancer Lett.193 ( 2 ), 207 – 216 ( 2003 ).
   PubMed Web of Science ®Google Scholar
• Goto K , IchinoseY , OheYet al. Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a Phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer . J. Thorac. Oncol.7 ( 1 ), 115 – 121 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Zhao X , HanRB , ZhaoJet al. Comparison of epidermal growth factor receptor mutation statuses in tissue and plasma in stage I-IV non-small cell lung cancer patients . Respiration85 ( 2 ), 119 – 125 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Ulivi P , MercataliL , CasoniGLet al. Multiple marker detection in peripheral blood for NSCLC diagnosis . PLoS ONE8 ( 2 ), e57401 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H , HoonDS , PantelK . Cell-free nucleic acids as biomarkers in cancer patients . Nat. Rev. Cancer11 ( 6 ), 426 – 437 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Bettegowda C , SausenM , LearyRJet al. Detection of circulating tumor DNA in early- and late-stage human malignancies . Sci. Transl. Med.6 ( 224 ), 224ra224 ( 2014 ).
   Web of Science ®Google Scholar
• Newman AM , BratmanSV , ToJet al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage . Nat. Med.20 ( 5 ), 548 – 554 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Diehl F , SchmidtK , ChotiMAet al. Circulating mutant DNA to assess tumor dynamics . Nat. Med.14 ( 9 ), 985 – 990 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Crowley E , Di NicolantonioF , LoupakisF , BardelliA . Liquid biopsy: monitoring cancer-genetics in the blood . Nat. Rev. Clin. Oncol.10 ( 8 ), 472 – 484 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Chan KC , JiangP , ChanCWet al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing . Proc. Natl Acad. Sci. USA110 ( 47 ), 18761 – 18768 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Warton K , LinV , NavinTet al. Methylation-capture and next-generation sequencing of free circulating DNA from human plasma . BMC Genomics15 ( 1 ), 476 ( 2014 ).
   PubMedGoogle Scholar
• Lun FM , ChiuRW , SunKet al. Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA . Clin. Chem.59 ( 11 ), 1583 – 1594 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Vaissiere T , CueninC , PaliwalAet al. Quantitative analysis of DNA methylation after whole bisulfitome amplification of a minute amount of DNA from body fluids . Epigenetics4 ( 4 ), 221 – 230 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Begum S , BraitM , DasguptaSet al. An epigenetic marker panel for detection of lung cancer using cell-free serum DNA . Clin. Cancer Res.17 ( 13 ), 4494 – 4503 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Wong IH , JohnsonPJ , LaiPB , LauWY , LoYM . Tumor-derived epigenetic changes in the plasma and serum of liver cancer patients. Implications for cancer detection and monitoring . Ann. N.Y. Acad. Sci.906 , 102 – 105 ( 2000 ).
   PubMed Web of Science ®Google Scholar
• Church TR , WandellM , Lofton-DayCet al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer . Gut63 ( 2 ), 317 – 325 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Iyer P , ZekriA-R , HungC-Wet al. Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients . Exp. Mol. Pathol.88 ( 1 ), 107 – 111 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Da Costa AN , PlymothA , Santos-SilvaDet al. Osteopontin and latent-TGF beta binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma . Int. J. Cancer136 ( 1 ), 172 – 181 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Bruix J , ShermanM . Management of hepatocellular carcinoma: an update . Hepatology53 ( 3 ), 1020 – 1022 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Forner A , ReigME , De LopeCR , BruixJ . Current strategy for staging and treatment: the BCLC update and future prospects . Semin. Liver Dis.30 ( 1 ), 61 – 74 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Kanda M , NomotoS , OkamuraYet al. Promoter hypermethylation of fibulin 1 gene is associated with tumor progression in hepatocellular carcinoma . Mol. Carcinog.50 ( 8 ), 571 – 579 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Kitamura Y , ShirahataA , SakurabaKet al. Aberrant methylation of the Vimentin gene in hepatocellular carcinoma . Anticancer Res.31 ( 4 ), 1289 – 1291 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Martin J , MagninoF , SchmidtKet al. Hint2, a mitochondrial apoptotic sensitizer down-regulated in hepatocellular carcinoma . Gastroenterology130 ( 7 ), 2179 – 2188 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Li LC , DahiyaR . MethPrimer: designing primers for methylation PCRs . Bioinformatics18 ( 11 ), 1427 – 1431 ( 2002 ).
   PubMed Web of Science ®Google Scholar
• Hoyo C , MurthaAP , SchildkrautJMet al. Methylation variation at IGF2 differentially methylated regions and maternal folic acid use before and during pregnancy . Epigenetics6 ( 7 ), 928 – 936 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Xi Y , LiW . BSMAP: whole genome bisulfite sequence MAPping program . BMC Bioinformatics10 , 232 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Thorvaldsdottir H , RobinsonJT , MesirovJP . Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration . Brief Bioinform.14 ( 2 ), 178 – 192 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wu H , WuX , ShenL , ZhangY . Single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing . Nat. Biotech.32 ( 12 ), 1231 – 1240 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Hernandez-Vargas H , LambertMP , Le Calvez-KelmFet al. Hepatocellular carcinoma displays distinct DNA methylation signatures with potential as clinical predictors . PLoS ONE5 ( 3 ), e9749 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Utsunomiya T , ShimadaM , MorineY , TajimaA , ImotoI . Specific molecular signatures of non-tumor liver tissue may predict a risk of hepatocarcinogenesis . Cancer Sci.05 ( 7 ), 749 – 754 ( 2014 ).
   Google Scholar
• Arai E , UshijimaS , GotohMet al. Genome-wide DNA methylation profiles in liver tissue at the precancerous stage and in hepatocellular carcinoma . Int. J. Cancer125 ( 12 ), 2854 – 2862 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Anwar SL , LehmannU . DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma . World J. Gastroenterol.20 ( 24 ), 7894 – 7913 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Selaru FM , DavidS , MeltzerSJ , HamiltonJP . Epigenetic events in gastrointestinal cancer . Am. J. Gastroenterol.104 ( 8 ), 1910 – 1912 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• Nogueira Da Costa A , HercegZ . Detection of cancer-specific epigenomic changes in biofluids: powerful tools in biomarker discovery and application . Mol. Oncol.6 ( 6 ), 704 – 715 ( 2012 ).
   PubMed Web of Science ®Google Scholar
• Hitchins MP , OwensSE , KwokCT , GodsmarkG , AlgarUF , RamesarRS . Identification of new cases of early-onset colorectal cancer with an MLH1 epimutation in an ethnically diverse South African cohort . Clin. Genet.80 ( 5 ), 428 – 434 ( 2011 ).
   PubMed Web of Science ®Google Scholar
• Diaz LA Jr , BardelliA . Liquid biopsies: genotyping circulating tumor DNA . J. Clin. Oncol.32 ( 6 ), 579 – 586 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Frattini M , GallinoG , SignoroniSet al. Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer . Cancer Lett.263 ( 2 ), 170 – 181 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Perego RA , CorizzatoM , BrambillaPet al. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma . Eur. J. Cancer44 ( 7 ), 1039 – 1047 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Zhang R , ShaoF , WuX , YingK . Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis . Lung Cancer69 ( 2 ), 225 – 231 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Huang ZH , LiLH , HuaD . Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients . Cancer Lett.243 ( 1 ), 64 – 70 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Banki F , MasonRJ , OhDet al. Plasma DNA as a molecular marker for completeness of resection and recurrent disease in patients with esophageal cancer . Arch. Surg.142 ( 6 ), 533 – 538 ( 2007 ).
   PubMedGoogle Scholar
• Anglim PP , AlonzoTA , Laird-OffringaIA . DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update . Mol. Cancer7 , 81 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Chang H , YiB , LiLet al. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients . Exp. Mol. Pathol.85 ( 2 ), 96 – 100 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Herceg Z , HainautP . Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis . Mol. Oncol.1 ( 1 ), 26 – 41 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Skvortsova TE , RykovaEY , TamkovichSNet al. Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation . Br. J. Cancer94 ( 10 ), 1492 – 1495 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Mirza S , SharmaG , ParshadR , SrivastavaA , GuptaSD , RalhanR . Clinical significance of Stratifin, ERalpha and PR promoter methylation in tumor and serum DNA in Indian breast cancer patients . Clin. Biochem.43 ( 4–5 ), 380 – 386 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Couraud S , Vaca PaniaguaF , VillarSet al. Non-invasive diagnosis of actionable mutations by deep sequencing of circulating-free DNA in non-small cell lung cancer: findings from BioCAST/IFCT-1002 . Clin. Cancer Res.20 ( 17 ), 4613 – 4624 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Forshew T , MurtazaM , ParkinsonCet al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA . Sci. Transl. Med.4 ( 136 ), 136ra168 ( 2012 ).
   Web of Science ®Google Scholar
• Li YW , KongFM , ZhouJP , DongM . Aberrant promoter methylation of the vimentin gene may contribute to colorectal carcinogenesis: a meta-analysis . Tumour Biol.35 ( 7 ), 6783 – 6790 ( 2014 ).
   PubMedGoogle Scholar
• Ulirsch J , FanC , KnaflGet al. Vimentin DNA methylation predicts survival in breast cancer . Breast Cancer Res. Treat.137 ( 2 ), 383 – 396 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Wu BJ , ZhouZP , LiWPet al. Abnormal hypermethylation and clinicopathological significance of FBLN1 gene in cutaneous melanoma . Tumour Biol.35 ( 1 ), 123 – 127 ( 2014 ).
   PubMedGoogle Scholar
• Xiao W , WangJ , LiHet al. Fibulin-1 is down-regulated through promoter hypermethylation and suppresses renal cell carcinoma progression . J. Urol.190 ( 1 ), 291 – 301 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Cheng YY , JinH , LiuXet al. Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer . Br. J. Cancer99 ( 12 ), 2083 – 2087 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Kukita Y , UchidaJ , ObaSet al. Quantitative identification of mutant alleles derived from lung cancer in plasma cell-free DNA via anomaly detection using deep sequencing data . PLoS ONE8 ( 11 ), e81468 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Rothe F , LaesJF , LambrechtsDet al. Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer . Ann. Oncol.25 ( 10 ), 1959 – 1965 ( 2014 ).
   PubMed Web of Science ®Google Scholar